Agenda and minutes
Venue: Committee Room 3 - Senedd. View directions
Contact: Claire Morris
Media
Senedd.TV: View the webcast
Expected timing | No. | Item |
---|---|---|
Transcript View
the meeting
transcript (PDF 780KB) View as HTML
(424KB) |
||
Introductions, apologies, substitutions and declarations of interest Minutes: 1.1
The Chair welcomed Members to the meeting. 1.2
Apologies were received from Dawn Bowden AM and Julie Morgan AM. |
||
(09.30 - 10.15) |
Use of anti-psychotic medication in care homes - evidence session 9 - Royal College of Occupational Therapists & Royal College of Speech and Language Therapists Karin
Orman, Royal College of Occupational Therapists Dr
Alison Stroud, Royal College of Speech and Language Therapists Beth
Bowen, Royal College of Speech and Language Therapists Supporting documents:
Minutes: 2.1
The Committee received evidence from representatives of the Royal College of Occupational
Therapists and Royal College of Speech and Language Therapists. |
|
(10.20 - 10.50) |
Use of anti-psychotic medication in care homes - evidence session 10 - Care Forum Wales Melanie
Minty, Care Forum Wales Steven
Ford, Care Forum Wales Supporting documents: Minutes: 3.1
The Committee received evidence from representatives of Care Forum Wales. |
|
Motion under Standing Order 17.42 to resolve to exclude the public from the meeting for the following item of business Minutes: 4.1
The Committee agreed the motion. |
||
(10.50 - 11.20) |
Inquiry into the physical activity of children and young people - inquiry refresh Supporting documents:
Minutes: 5.1
The Committee had further discussions about its inquiry into the physical
activity of children and young people and agreed to issue invites to stakeholders
to attend evidence gathering sessions in the spring term. |
|
(11.35 - 12.05) |
Use of anti-psychotic medication in care homes - evidence session 11 - Care and Social Services Inspectorate Wales David
Francis, Assistant Chief Inspector, Care and Social Services Inspectorate Wales Supporting documents: Minutes: 6.1
The Committee received evidence from representatives of the Care and Social
Services Inspectorate Wales. 6.2
David Francis agreed to provide the Committee with a breakdown of the number care
homes in Wales which had been closed by CSSIW for poor service provision. |
|
(12.45 - 13.30) |
Use of anti-psychotic medication in care homes - evidence session 12 - Cwm Taf University Health Board and Cardiff and Vale University Health Board Mr
John Palmer, Director of Primary, Community and Mental Health, Cwm Taf UHB Mrs
Kim Williams, Consultant Psychologist Older Persons Mental Health, Cwm Taf UHB Victoria
Gimson, Specialist Mental Health Pharmacist, Cardiff and Vale UHB Candace
Rowlands, Cardiff and Vale UHB Supporting documents:
Minutes: 7.1
The Committee received evidence from representatives of Cwm Taf University
Health Board and Cardiff and Vale University Health Board. |
|
(13.35 - 14.20) |
Use of anti-psychotic medication in care homes - evidence session 13 - Aneurin Bevan University Health Board and Hywel Dda University Health Board Claire
Aston, Divisional Nurse/Head of Complex Care, Aneurin Bevan UHB Dr
Chineze Ivenso, Old Age Consultant Psychiatrist (Newport Community Mental
Health Team), Aneurin Bevan UHB Sarah
Isaac, Senior Pharmacist Manager – Primary Care, Hywel Dda UHB Sue
Stephens, Prescribing Advisor, Hywel Dda UHB Minutes: 8.1
The Committee received evidence from representatives of Aneurin Bevan
University Health Board and Hywel Dda University Health Board. 8.2
Dr Chineze Ivenso agreed to provide the Committee with the findings, so far, of
the 2017 audits on the use of antipsychotic medication with patients who have
dementia living in care home settings in the Newport borough. 8.3
Both Health Boards agreed to write to the Committee setting out what data on
antipsychotic prescribing they believed should be collected nationally to
enable health boards to benchmark against other and against NICE standards. |
|
Paper(s) to note |
||
Use of antipsychotic medication in care homes - additional information from Community Pharmacy Wales Supporting documents: Minutes: 9.1a
The Committee noted the additional information from Community Pharmacy Wales in
relation to the inquiry into the use of antipsychotic medication in care homes. |
||
Letter from the Cabinet Secretary for Health, Well-being and Sport regarding the upcoming Committee inquiry into suicide prevention Supporting documents: Minutes: 9.2a
The Committee noted the letter from the Cabinet Secretary for Health,
Well-being and Sport in relation to the upcoming Committee inquiry into suicide
prevention. |
||
Letter from the Chair of the Public Accounts Committee regarding the NHS Finance (Wales) Act 2014 Supporting documents: Minutes: 9.3a
The Committee noted the letter from the Chair of the Public Accounts Committee
regarding the NHS Finance (Wales) Act 2014. |
||
Motion under Standing Order 17.42 to resolve to exclude the public from the remainder of the meeting Minutes: 10.1
The Committee agreed the motion. |
||
(14.20 - 14.35)) |
Use of anti-psychotic medication in care homes - consideration of evidence Minutes: 11.1
The Committee considered the evidence given during items 2, 3, 6, 7 and 8 of
the meeting. |